TNSN02003A1 - Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant. - Google Patents

Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant.

Info

Publication number
TNSN02003A1
TNSN02003A1 TNTNSN02003A TNSN02003A TNSN02003A1 TN SN02003 A1 TNSN02003 A1 TN SN02003A1 TN TNSN02003 A TNTNSN02003 A TN TNSN02003A TN SN02003 A TNSN02003 A TN SN02003A TN SN02003 A1 TNSN02003 A1 TN SN02003A1
Authority
TN
Tunisia
Prior art keywords
histamine
antagonist
combination
composition containing
same
Prior art date
Application number
TNTNSN02003A
Other languages
English (en)
French (fr)
Inventor
Jenkinson Stephen
Anthony O'reilly Mark
Andrew Trevethick Michael
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN02003A1 publication Critical patent/TNSN02003A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TNTNSN02003A 2001-01-17 2002-01-16 Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant. TNSN02003A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
TNSN02003A1 true TNSN02003A1 (fr) 2005-12-23

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN02003A TNSN02003A1 (fr) 2001-01-17 2002-01-16 Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant.

Country Status (31)

Country Link
EP (1) EP1353657A1 (de)
JP (1) JP2004517883A (de)
KR (1) KR20030069216A (de)
CN (1) CN1486178A (de)
AP (1) AP2002002401A0 (de)
AR (1) AR032101A1 (de)
BG (1) BG107834A (de)
BR (1) BR0206502A (de)
CA (1) CA2435121A1 (de)
CR (1) CR6983A (de)
CZ (1) CZ20031853A3 (de)
DO (1) DOP2002000325A (de)
EA (1) EA200300537A1 (de)
EC (1) ECSP034692A (de)
EE (1) EE200300335A (de)
GB (1) GB0101223D0 (de)
GT (1) GT200200003A (de)
HU (1) HUP0302767A2 (de)
IL (1) IL156087A0 (de)
IS (1) IS6818A (de)
MA (1) MA26980A1 (de)
MX (1) MXPA03006408A (de)
NO (1) NO20033223L (de)
OA (1) OA12440A (de)
PA (1) PA8537101A1 (de)
PL (1) PL362793A1 (de)
SK (1) SK8572003A3 (de)
SV (1) SV2003000849A (de)
TN (1) TNSN02003A1 (de)
WO (1) WO2002056871A2 (de)
ZA (1) ZA200304180B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
WO2004021999A2 (en) * 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. Use of histamine h4 receptor modulators for the treatment of allergy and asthma
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) * 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP3378476A1 (de) 2012-06-08 2018-09-26 Sensorion H4-rezeptor-inhibitoren zur behandlung von tinnitus

Also Published As

Publication number Publication date
BR0206502A (pt) 2003-10-21
SV2003000849A (es) 2003-01-13
NO20033223D0 (no) 2003-07-16
PL362793A1 (en) 2004-11-02
HUP0302767A2 (hu) 2003-11-28
OA12440A (en) 2006-05-22
EA200300537A1 (ru) 2004-02-26
EP1353657A1 (de) 2003-10-22
ECSP034692A (es) 2003-08-29
EE200300335A (et) 2003-12-15
GB0101223D0 (en) 2001-02-28
MXPA03006408A (es) 2003-10-15
PA8537101A1 (es) 2002-08-29
CR6983A (es) 2003-11-25
ZA200304180B (en) 2004-06-15
CN1486178A (zh) 2004-03-31
JP2004517883A (ja) 2004-06-17
NO20033223L (no) 2003-07-16
IL156087A0 (en) 2003-12-23
BG107834A (bg) 2004-01-30
GT200200003A (es) 2002-08-19
CA2435121A1 (en) 2002-07-25
AP2002002401A0 (en) 2002-03-31
IS6818A (is) 2003-05-15
KR20030069216A (ko) 2003-08-25
AR032101A1 (es) 2003-10-22
SK8572003A3 (en) 2004-07-07
CZ20031853A3 (cs) 2004-07-14
DOP2002000325A (es) 2003-01-31
WO2002056871A2 (en) 2002-07-25
MA26980A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
TNSN01053A1 (fr) Compositions nouvelles comprenant un agoniste partiel des recepteurs de nicotine et un agent analgesique
FR2814678B1 (fr) Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
ATE252560T1 (de) Steroidrezeptor-modulator verbindungen und methoden
MA27028A1 (fr) Agoniste de recepteur d'adenosine a2a et agent anticholinergique en association pour le traitement de maladies obstructives des voies aeriennes
BR9912406A (pt) Compostos de anilida substituida e métodos
TNSN98017A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN00183A1 (fr) COMPOSITIONS COMPRENANT LE POLYPEPTIDE IL-1ra ET UN INHIBITEUR DE MATURATION ET DE LIBERATION DE IL-1 ET METHODES DE TRAITEMENT LES UTILISANT
TNSN01040A1 (fr) Compositions nouvelles comprenant des inhibiteurs de glycogene- phosphorylase
TNSN01173A1 (fr) Compositions pharmaceutiques comprenant un antagoniste des recepteurs de nmda.
TNSN98179A1 (fr) Medicaments
YU7797A (sh) Kombinovana terapija za osteoporozu
BR9813957A (pt) Uso de antagonistas da vasopressina
TNSN98227A1 (fr) Association pharmaceutique pour le traitement d'un dysfonctionnement sexuel et compositions la contenant.
MA27101A1 (fr) Composition pharmaceutique orodispersible d'agomelatine
MA29487B1 (fr) Preparation de type emulsion stable
TNSN02003A1 (fr) Association d'un antagoniste des recepteurs d'histamine h1 et d'un antagoniste selectif des recepteurs d'histamine h4, et composition la contenant.
DE69906944D1 (de) 20-hete antagonisten und agonisten
ATE348812T1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
TNSN01144A1 (fr) Derives de piperazine pontes, et compositions les contenant.
BR0015980A (pt) Agente para profilaxia ou tratamento do glaucoma, e, uso de um antagonista de angiotensina ii
YU39201A (sh) Upotreba 1-arilpirazola za pripremanje oralnog sredstva za suzbijanje parazita
MA28276A1 (fr) Preparation effervescente d'une substance basique a action pharmaceutique
BR0212582A (pt) Combinação
BR0213183A (pt) Uso de ativadores gp130 em neuropatia diabética
FR2848454B1 (fr) Composition pharmaceutique comprenant une association de calcitriol et d'un corticosteroide